Many advisors are already fielding calls from clients about their drug plans, says head of benefits association.

Sun Life and Ipsos research paper looks at gender health gap.

Industry’s concerns remain unaddressed – a missed opportunity, says association CEO.

Immune disorders and diabetes remain top conditions for drug spending in 2023.

Patented Medicine Prices Review Board looks at Canadian sales of new medicines.

The Canadian Life & Health Insurance Association says Bill C-64 must be read in its entirety to understand the implicati…

Clients also given access to care program that includes one-on-one health support.